Patient “recovering really well” after life-saving aorta surgery in Brisbane
Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
News and Insights of 3D Printing and Manufacturing
HomeMedical
Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense!
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense!
U.S.-based 3D printer manufacturer 3D Systems, in partnership with French MedTech firm TISSIUM, has secured FDA approval for a bioabsorbable, 3D printed device designed to treat peripheral nerve damage. This approval validates the polymer’s clinical effectiveness and paves the way for its use across a wide range of medical treatments.
The U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) and the University of Hawaii System recently formalized a collaborative initiative to enhance warfighter survivability and effectiveness. This partnership, strategically focused on leveraging biomaterials and advanced manufacturing capabilities, aims to strengthen defense efforts, particularly in support of the United States Indo-Pacific Command, which is headquartered in Hawaii.
US-based biotechnology company Continuity Biosciences has invested in 3D printed microneedle technology specialist PinPrint to expand its focus from therapeutic delivery into aesthetic and cosmetic applications.
French medical device company PROTEOR has acquired Filament Innovations, a company specializing in 3D printing technologies for the orthotics and prosthetics (O&P) industry. The acquisition broadens PROTEOR’s digital solutions portfolio to include scanning, rectification, and 3D printing tools, supporting the development of customized medical device solutions.
Triastek, a Chinese 3D printing pharmaceutical company, has announced that its proprietary 3D printed non-vitamin K antagonist oral anticoagulant (NOAC), T20G, has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) as of February 27, 2025. This regulatory achievement follows an earlier IND approval from China’s National Medical Products Administration (NMPA) in January 2024.
Axtra3D, a developer of high-speed stereolithography (SLA) systems, has introduced four new dental resins, expanding its portfolio of validated materials for the Lumia X1 printer. The new additions—NextDent Model Sand, Pro3dure Splint 19.1 AO/MSI, Pro3dure Denture 14.2, and Pro3dure Crown & Bridge—are now available with optimized print profiles, aimed at increasing accuracy and production efficiency for digitally manufactured dental models, splints, dentures, and restorations.
A group of Chinese researchers have developed a novel approach for addressing erectile dysfunction (ED) using biomedical 3D printing.